Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2010067286) IgE CH3 PEPTIDE VACCINE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2010/067286 International Application No.: PCT/IB2009/055508
Publication Date: 17.06.2010 International Filing Date: 04.12.2009
IPC:
A61K 39/00 (2006.01) ,C07K 16/00 (2006.01) ,A61P 37/08 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39
Medicinal preparations containing antigens or antibodies
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
K
PEPTIDES
16
Immunoglobulins, e.g. monoclonal or polyclonal antibodies
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
37
Drugs for immunological or allergic disorders
08
Antiallergic agents
Applicants:
PFIZER VACCINES LLC [US/US]; 235 East 42nd Street New York, New York 10017-5755, US (AllExceptUS)
BROWN, Alan Daniel [GB/GB]; GB (UsOnly)
CHAMPION, Brian Robert [GB/GB]; GB (UsOnly)
CHRISTY, Clare [GB/GB]; GB (UsOnly)
GERVAIS, David Paul [GB/GB]; GB (UsOnly)
JONES, Lyn Howard [GB/GB]; GB (UsOnly)
KJERRSTROM, Anne Maria Kristina [SE/GB]; GB (UsOnly)
PRYDE, David Cameron [GB/GB]; GB (UsOnly)
ROBERTS, Lee Richard [GB/GB]; GB (UsOnly)
WYATT, David Michael [GB/GB]; GB (UsOnly)
Inventors:
BROWN, Alan Daniel; GB
CHAMPION, Brian Robert; GB
CHRISTY, Clare; GB
GERVAIS, David Paul; GB
JONES, Lyn Howard; GB
KJERRSTROM, Anne Maria Kristina; GB
PRYDE, David Cameron; GB
ROBERTS, Lee Richard; GB
WYATT, David Michael; GB
Agent:
DROUIN, Stephane; Pfizer Global Research and Development Ramsgate Road Sandwich Kent CT13 9NJ, GB
Priority Data:
61/120,98909.12.2008US
Title (EN) IgE CH3 PEPTIDE VACCINE
(FR) VACCIN PEPTIDIQUE IGE CH3
Abstract:
(EN) The present invention relates to the provision of immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
(FR) L'invention concerne l'utilisation de nouveaux immunogènes comprenant un peptide antigène IgE lié, de préférence à un support immunogène, destinés à prévenir, traiter ou soulager des troubles induits par IgE. L'invention concerne également des procédés de production de ces médicaments, des compositions immunogènes et des compositions pharmaceutiques de celles-ci et leur utilisation en médecine.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)